Genicular Artery Embolization Side Effects and Risks: What the Research Actually Shows

Any honest conversation about a medical procedure includes the downside. If a website only tells you about the upside, you should be skeptical of the website.

So here is a direct look at what the published research says about the risks and side effects of genicular artery embolization, what patients most commonly experience, what is rare, and what Dr. Russell Becker does to minimize it.

The overall safety picture

GAE has now been studied across dozens of published trials. A recent systematic review and meta-analysis pooled 45 studies covering more than 2,200 patients. Other systematic reviews and sham-controlled randomized trials have looked at the same question from different angles.

The consistent finding across that literature is that side effects do occur, they are common enough that you should expect the possibility of one, and they are overwhelmingly minor and self-limiting. The large pooled analyses have not reported severe or life-threatening complications attributable to the procedure. That is a genuinely good safety profile. It is not the same as "no risk," and we are not going to describe it that way.

The most common side effect: temporary skin discoloration

This is the one to know about, because it is the most frequently reported.

‍

What it is: A change in skin color over part of the knee, usually a mild reddish or purplish discoloration in a patch of skin near the treated area.

Why it happens: The genicular arteries form a rich, interconnected network. Some of the tiny embolic particles can travel slightly beyond the intended target and briefly affect the small vessels supplying the skin. This is called non-target embolization.

How common: Reported rates vary considerably across studies depending on how closely investigators looked for it. A large pooled meta-analysis put it at roughly 11%. Individual studies have reported figures ranging from about 5% to substantially higher, largely reflecting differences in how systematically each study documented it.

How long it lasts: It is characteristically transient. In the published series, these skin changes resolve on their own, typically over days to weeks, without treatment or lasting effect.

Access site issues

Because GAE is performed through a small puncture in an artery, usually at the wrist or upper thigh, the risks common to any catheter-based procedure apply.

‍

Bruising and hematoma. A collection of blood under the skin at the puncture site. Pooled analyses put clinically noted hematoma at roughly 3%, though rates of any-size bruising run higher. It is managed with pressure and typically resolves without intervention.

Soreness at the access site. Common, mild, and usually gone within a day or two.

‍

The techniques that reduce these risks are well established: careful pre-procedure review of anticoagulation and clotting status, appropriate compression, and closure technique. This is standard practice in a vascular surgery setting.

Post-embolization syndrome

A small number of patients generally experience a short-lived inflammatory response after embolization procedures. It can include low-grade fever, mild nausea, fatigue, or a temporary increase in knee discomfort. It is uncommon after GAE specifically, typically lasts a day or two, and is managed supportively.

If you develop a fever after your procedure, call the office. We would rather hear from you and tell you it is expected than have you sit at home wondering.

The rarer risks worth naming

These are uncommon, and in some cases reported only in isolated cases across the literature. We name them anyway, because informed consent means knowing what is on the list.

• Plantar paresthesia. Temporary tingling or altered sensation in the foot, related to the anatomical connections between the genicular circulation and vessels supplying nerves in the lower leg. Recognizing and avoiding these connections during the procedure is a technical skill, and it is one of the clearest arguments for choosing an experienced operator.
• Small bone infarction. In one imaging surveillance study, a small number of patients had tiny areas of reduced bone blood supply visible on follow-up MRI. These were small, located in non-weight-bearing portions of the joint, caused no symptoms, and were associated with no adverse events at one year. Longer-term significance is still being studied.
• Increased joint pain in the short term, vessel spasm, and, very rarely, infection at the access site.
• Contrast and radiation exposure. GAE uses iodinated contrast and fluoroscopic imaging. Patients with significant kidney impairment or a history of contrast reaction need that factored into planning.

What about future knee replacement?

This comes up constantly, and it deserves a precise answer rather than a slogan.

GAE does not enter or alter the knee joint. Nothing is cut, removed, or replaced. Your structural candidacy for total knee replacement is preserved.

A 2025 multi-institution study specifically examined patients who went on to have knee arthroplasty after a prior GAE. Adverse events after the arthroplasty were uncommon, limited to minor wound-healing issues in a small number of cases, and all of them resolved. That is reassuring data, and it is more useful than an unqualified "no effect at all."

The practical takeaway: choosing GAE does not close the door on surgery later. If you do eventually pursue replacement, tell your orthopedic surgeon you have had GAE, the same way you would disclose any prior procedure.

Who may not be a good candidate

Risk management starts with patient selection, not with technique. GAE may not be appropriate if:

• Your knee pain is driven primarily by a mechanical problem rather than inflammation, such as significant joint deformity, ligament instability, or a structural issue requiring surgical correction
• You have an active infection
• You have severe peripheral arterial disease affecting the vessels needed for access or navigation
• You have significant kidney impairment or a serious history of contrast reaction, though this is sometimes workable with planning
• You have a bleeding disorder or are on anticoagulation that cannot be safely adjusted

If GAE is not the right tool for your knee, Dr. Becker will tell you that directly and refer you to the specialist who is.

Why operator experience is part of the safety equation

Most of the meaningful risks in GAE are technical: recognizing the vascular connections that lead to non-target embolization, selecting the right particle size, and knowing when to stop. Those are judgment calls made in real time during the procedure.

Dr. Russell Becker is a fellowship-trained vascular surgeon who pursued dedicated GAE training internationally, including in Tokyo, and has performed more than 50 GAE procedures in his accredited in-office suite at the Vascular Center of Naples. He performs every procedure himself. There are no handoffs.

When you are evaluating the safety of a procedure, the operator is not a footnote. It is a large part of the answer.

Frequently Asked Questions

Is genicular artery embolization safe?

Across published systematic reviews covering thousands of patients, GAE has demonstrated a favorable safety profile with no severe or life-threatening complications reported. Minor side effects, most commonly temporary skin discoloration and access site bruising, do occur and typically resolve on their own.

‍

What is the most common side effect of GAE?

Temporary skin discoloration near the treated knee. Pooled data puts it at roughly 11%, with wide variation across studies. It resolves on its own without treatment.

‍

How long do GAE side effects last?

The common ones are short-lived. Access site soreness and bruising typically resolve within days. Skin discoloration typically resolves over days to weeks. Post-embolization symptoms, when they occur, usually last a day or two.

‍

Can GAE damage my knee joint?

The procedure works entirely through the blood vessels and does not enter the joint space. Nothing is cut or removed. Small, asymptomatic areas of reduced bone blood supply have been identified on research imaging in a small number of patients without associated symptoms or adverse events at one year.

‍

Am I too old for GAE?

Age alone is rarely the limiting factor. In fact, patients who face elevated risk from major surgery, whether due to age, cardiovascular disease, diabetes, or weight, are often the patients for whom a minimally invasive, no-general-anesthesia option makes the most sense. What matters is your overall vascular health and your specific clinical picture.

‍

What should I call the office about after my procedure?

Fever, worsening pain rather than improving pain, expanding swelling or bleeding at the access site, or any new numbness or color change in your foot. Call us. That is what we are here for.

‍

Have questions about whether GAE is safe for your specific situation? That is exactly the conversation to have with Dr. Becker. Find out if you're a candidate. Schedule a consultation at the Vascular Center of Naples. Call (239) 431-5884.

‍

Find Out If You Are a Candidate

‍

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice. Individual risks vary based on personal health history and clinical circumstances. Please consult a qualified physician for diagnosis and individualized treatment recommendations.

‍